SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 489.22 |
| Enterprise Value ($M) | 221.82 |
| Book Value ($M) | -28.29 |
| Book Value / Share | -0.51 |
| Price / Book | -17.29 |
| NCAV ($M) | -69.26 |
| NCAV / Share | -1.25 |
| Price / NCAV | -7.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -8.46 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.71 |
| Current Ratio | 4.71 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 267.40 |
| Assets | 308.37 |
| Liabilities | 336.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Klarman Family Foundation | 3.90 | ||
| 13G | Flynn James E | 5.31 | ||
| 13G/A | Fmr Llc | 11.39 | 124.31 | |
| 13G | Biotechnology Value Fund L P | 9.99 | ||
| 13D/A | Flagship Ventures Fund V, L.P. | 22.90 | 28.64 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 56,055 | 232,695 | 24.09 | |
| 27,770 | 115,145 | 24.12 | |
| 48,536 | 126,983 | 38.22 | |
| 15,703 | 98,686 | 15.91 | |
| 10,277 | 107,563 | 9.55 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ETON – Eton Pharmaceuticals, Inc. | FATE – Fate Therapeutics, Inc. |
| FBLG – FibroBiologics, Inc. | FOLD – Amicus Therapeutics, Inc. |
| FULC – Fulcrum Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io